Skip to main content

HPA Global

International Probiotics Association Announces 2026 Biotic Innovation Award Winner for Gut Microbiome and Cancer Research

November 3, 2026

The International Probiotics Association (IPA) has announced Dr. Marine Fidelle, PhD, as the winner of the second annual Jarrow Rogovin IPA Biotic Innovation Award, recognizing her innovative research exploring the relationship between the gut microbiome, cancer immunotherapy, and precision medicine.

Dr. Fidelle, affiliated with Université Paris-Saclay and the Gustave Roussy cancer research center in France, received the $5,000 award for her work investigating how gut microorganisms interact with metabolism and the immune system to influence cancer development and treatment outcomes.

Her research has identified mechanisms linking microbial imbalances, bile acid metabolism, and intestinal immune-cell trafficking to resistance to immune checkpoint inhibitors, a class of cancer treatments designed to help the immune system recognize and attack cancer cells.

The research has also contributed to identifying promising biomarkers, including soluble MAdCAM-1 and circulating histidine, which could help researchers better understand individual responses to cancer immunotherapy.

Through international collaborations, transparent data sharing, and mentorship, Dr. Fidelle is helping connect scientific discoveries involving the microbiome with potential clinical applications.

Her current research explores microbiome-based biomarkers and microbiota-targeted therapies that could improve immunotherapy outcomes and enable earlier intervention in cancer development.

The Jarrow Rogovin IPA Biotic Innovation Award was established through a legacy endowment from Jarrow Rogovin, a pioneer in the probiotics industry who helped advance scientific understanding and commercial development of probiotics.

Rogovin began advocating for probiotics in 1999, before the World Health Organization and Food and Agriculture Organization established their widely recognized definition of probiotics. He subsequently founded and guided several innovative companies focused on scientifically supported biotic products.

The award recognizes exceptional scientific excellence and translational impact involving the human and companion animal microbiome, probiotics, prebiotics, synbiotics, and postbiotics.

IPA also announced that applications for the next award cycle will open in 2027.

What this means for the industry

The recognition of Dr. Fidelle’s research highlights the expanding scientific importance of the gut microbiome beyond traditional digestive and immune health applications.

Microbiome research is increasingly investigating how microorganisms and their metabolites influence systemic health, immune regulation, and responses to medical treatments.

For probiotic and functional ingredient developers, these advances reinforce the importance of strain-specific research, microbial metabolite analysis, and understanding the complex interactions between the microbiome and human physiology.

The research also illustrates the growing potential for precision microbiome approaches, in which microbial biomarkers may eventually help identify individuals most likely to benefit from particular medical interventions.

However, the findings remain part of an evolving field of biomedical research and should not be interpreted as evidence that commercially available probiotic supplements can prevent cancer or improve cancer-treatment outcomes.

For the global probiotics industry, the Jarrow Rogovin IPA Biotic Innovation Award demonstrates the value of supporting early-stage scientific discoveries and strengthening collaboration between academic researchers, clinicians, and industry.

Source: International Probiotics Association (IPA), Jarrow Rogovin IPA Biotic Innovation Award, 2026 award announcement.

Original source: IPA’s 2026 publication, provided in the accompanying photograph. International Probiotics Association website


About HPA-Global

If your company is active in the dietary supplement, functional food, ingredient, or health products industry and is not yet a member of HPA-Global, we invite you to consider joining the association.

HPA-Global supports members with China and global market intelligence, marketing visibility, industry connections, and access to regulatory support for supplements, ingredients, and related health products in China, the EU, Japan, South Korea, and the U.S.

For companies looking to expand internationally and stay ahead of market and regulatory changes, HPA-Global offers one of the best values in the industry.

For more news, visit: www.hpaglobal.org/news

For more information about HPA-Global membership and services, visit: www.hpaglobal.org/connect